AACR: Molecule Promising Against Basal Cell Carcinoma
http://... Von Hoff, M.D., of the Scottsdale Clinical Research Institute in ArizonaSAN DIEGO, April 15 -- Eight of nine patients with metastatic basal cell carcinoma had durable clinical benefit with minimal toxicity when treated with an investigational compound that inhibits signaling in the Hedgehog pathway.